From Forbes:

The femtech industry has experienced remarkable growth in recent years, both in terms of investment and innovation. In fact, Deloitte has reported that femTech is expected to hit a market value of over $100 billion by 2032. And McKinsey values the overall women’s health market at $1 trillion annually by 2040.

This momentum reflects a growing recognition of gender-specific healthcare needs within the public awareness, legislation and investors, underscored by the advocacy of leaders such as Vice President Kamala Harris, the First Lady Jill Biden and Melinda French Gates. These advocates have championed issues from maternal mortality to reproductive rights in order to bring meaningful advances to women’s health in the United States.

As the Biden administration draws to a close, the focus turns to the future: What’s next for women’s health, and how can we sustain and expand on this progress under a new government?